A Community-transmitted Case of Severe Acute Respiratory Distress Syndrome (SARS) Due to SARS-CoV-2 in the United States

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com..

This is the first known community transmission case of the novel coronavirus disease (COVID-19) in the United States, with significant public health implications. Diagnosis of COVID-19 is currently confirmed with PCR based testing of appropriate respiratory samples. Given the absence of travel or known exposure history, this patient did not meet the criteria for testing according to CDC guidelines at the time of her presentation. Since this case, any patient with severe disease (eg, ARDS or pneumonia) requiring hospitalization without an explanatory diagnosis can be tested even if no clear source of exposure is identified. While influencing national health policies for revising screening criteria, this case also highlighted significant knowledge gaps in diagnosis and treatment and a desperate need for early, widespread, fast and cheap testing for COVID-19.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:71

Enthalten in:

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 71(2020), 16 vom: 19. Nov., Seite 2222-2226

Sprache:

Englisch

Beteiligte Personen:

Sanville, Bradley [VerfasserIn]
Corbett, Rebecca [VerfasserIn]
Pidcock, Wesley [VerfasserIn]
Hardin, Kaitlyn [VerfasserIn]
Sebat, Christian [VerfasserIn]
Nguyen, Minh-Vu [VerfasserIn]
Thompson, George R [VerfasserIn]
Haczku, Angela [VerfasserIn]
Schivo, Michael [VerfasserIn]
Cohen, Stuart [VerfasserIn]

Links:

Volltext

Themen:

3QKI37EEHE
415SHH325A
Adenosine Monophosphate
Alanine
Antiviral Agents
COVID-19
Case Reports
Community transmission
Index case
Journal Article
Novel coronavirus
OF5P57N2ZX
Remdesivir
SARS-CoV-2

Anmerkungen:

Date Completed 04.12.2020

Date Revised 07.12.2022

published: Print

Citation Status MEDLINE

doi:

10.1093/cid/ciaa347

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM308128788